PHARMACY CARE NICOTINE LOZENGES 4mg nicotine (as nicotine polacrilex) lozenge blister pack

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

유효 성분:

nicotine polacrilex, Quantity: 26.66 mg (Equivalent: nicotine, Qty 4 mg)

제공처:

Orion Laboratories Pty Ltd T/A Perrigo Australia

INN (International Name):

Nicotine polacrilex

약제 형태:

Tablet, uncoated

구성:

Excipient Ingredients: aspartame; sodium alginate; xanthan gum; potassium bicarbonate; magnesium stearate; sodium carbonate; mannitol; Flavour

관리 경로:

Buccal

패키지 단위:

156, 120, 36, 168, 144, 96, 72, 108, 132

처방전 유형:

Not Scheduled after consideration by Committee

치료 징후:

Relief of nicotine withdrawal symptoms including cravings associated with smoking cessation. Nicotine Lozenges may also be used as part of a smoking reduction strategy by smokers who are unable or not ready to stop smoking abruptly as a step towards stopping smoking. If possible, when stopping smoking, should be used in conjunction with behavioural support program.

제품 요약:

Visual Identification: Cream/white embossed biconvex round tablet with a peppermint odour. Embossed with ?L873? on one face; Container Type: Blister Pack; Container Material: PVC/PCTFE (Aclar)/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

승인 상태:

Licence status A

승인 날짜:

2014-12-16